Carlsmed, Inc.
corporate_fare Company Profile
Carlsmed, Inc. (NASDAQ:CARL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for CARL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for CARL spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- Carlsmed 10-Q Details Q3 Revenue of $21.6M, 77.3% Gross Margin and $80.3M Liquidity
- Carlsmed Q3 Revenue Jumps 65% to $21.6M, Full-Year Guidance Raised to $78-80M
- Q3 Revenue Jumps 65% to $21.6M, Full-Year Guidance Raised to $78-80M
- Carlsmed Names Richard Heppenstall CFO, Reaffirms FY26 Revenue Guidance of $74–78M
- Carlsmed Sues DeGen Medical Over Eight Spine Surgery Patents
Financial Snapshot
Short Interest & Short Volume
15.07 days to coverFINRA reported short interest of 1,241,498 shares in CARL as of the October 30, 2026 settlement, a 13.4% increase from the prior period — about 15.1 days to cover at its recent average daily volume. On November 19, 2026, 46.5% of CARL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CARL, detected from its recent SEC filings.
$250M Universal Shelf Registered · No Immediate Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →